Vaccine News and Research

Latest Vaccine News and Research

Oncothyreon proposes underwritten public offering of common stock

Oncothyreon Inc. today announced its intention to offer, subject to market and other conditions, shares of its common stock in an underwritten public offering.

29 Mar 2012

Vaccination for HPV reduces risk of renewed disease

The vaccination against human papillomavirus (HPV) reduces the risk of a renewed HPV-associated illness in patients who have already had diseases as a consequence of an HPV infection.

29 Mar 2012

CDC Director provides update on AIDS epidemic in anticipation of AIDS 2012 conference

In anticipation of the AIDS 2012 conference, to be held in Washington, D.C., from July 22-27, CDC Director Thomas Frieden spoke at the Washington-based Center for Strategic & International Studies, where he provided an update on the epidemic in the U.S. and abroad, VOA News reports.

29 Mar 2012

Greater out-of-pocket asthma medication costs associated with frequent hospitalizations among children

Greater out-of-pocket asthma medication cost was associated with small reductions in medication use and with more frequent asthma-related hospitalizations among children ages 5 years or older, according to a study in the March 28 issue of JAMA.

28 Mar 2012

Cholera vaccination campaign still stalled in Haiti, NPR reports

A planned mass cholera vaccination project in Haiti continues to be "bogged down in bureaucratic red tape," as spring rains begin and the number of cholera cases starts to rise, NPR's health blog "Shots" reports.

28 Mar 2012

Pakistan's draft bill that would punish parents for not vaccinating children 'misses the mark'

"Eradicating polio and improving the health of millions of children in Pakistan depend quite heavily on assuring that all children have access to life-saving vaccines," but "the most recent policy prescription from the Pakistani parliament to improve immunization coverage, however, misses the mark, and badly," Orin Levine, executive director of the International Vaccine Access Center, writes in this Huffington Post "World" blog post.

28 Mar 2012

Study: 20.1M individuals infected with HEV across 9 world regions

New research funded by the World Health Organization (WHO) estimates that 20.1 million individuals were infected with hepatitis E virus (HEV) genotypes 1 and 2 across 9 world regions in 2005.

28 Mar 2012

Gold nanoparticles used to introduce chemical residues into the immune system

Developing a drug or vaccine requires a delicate balancing act with the immune system. On one hand, medications need to escape detection by the immune system in order to perform their function. But vaccinations - de-activated versions of a disease or virus - need to do the reverse. They prompt the immune system to create protective antibodies.

27 Mar 2012

Report explores expanding influence of BRICS on global health and development

Brazil, Russia, India, China and South Africa are injecting new resources, momentum and innovation into efforts to improve health in the world's poorest countries, according to a report released on the eve of the 2012 BRICS Summit. Coming as many traditional donors reduce or slow their spending, the report explores the expanding influence of the BRICS on global health and development.

27 Mar 2012

NY-ESO-1 vaccine shows promise against ovarian cancer, melanoma

An immunotherapy regimen incorporating poxviruses and targeting a particular tumor antigen, NY-ESO-1, has shown promise in treating two types of cancers.

27 Mar 2012

MedImmune receives FDA approval for FluMist Quadrivalent vaccine

FluMist Quadrivalent, a vaccine to prevent seasonal influenza in people ages 2 years through 49 years, has been approved today by the U.S. Food and Drug Administration. FluMist Quadrivalent is the first influenza vaccine to contain four strains of the influenza virus, two influenza A strains and two influenza B strains.

27 Mar 2012

BRICS countries increasing global health, development aid, report says

As their economies grow, Brazil, Russia, India, China and South Africa -- known collectively as BRICS -- "are injecting new resources, innovation and momentum into efforts to improve health in the world's poorest countries, according to a report by Global Health Strategies initiatives [GHSi]" released on Monday, Business Live reports.

27 Mar 2012

Opinion pieces, editorials, blog posts recognize World TB Day

Saturday, March 24, was World Tuberculosis (TB) Day. The following is a summary of several editorials, opinion pieces, and blog posts published in recognition of the day.

27 Mar 2012

IU biologist to genetically modify variants of chlamydia

An Indiana University biologist has been awarded over $2.3 million from the National Institutes of Health to genetically modify variants of the human pathogen chlamydia in hopes of finding a vaccine for the most commonly reported bacterial infectious disease in the United States.

27 Mar 2012

Vaccine to prevent Campylobacter in chickens can help reduce food-borne illness

A vaccine could be developed to prevent Campylobacter being carried in chickens. This approach could drastically cut the number of cases of food poisoning, saving the UK economy millions each year, says an American scientist presenting his work at the Society for General Microbiology's Spring Conference in Dublin.

27 Mar 2012

Time for no-fault vaccination compensation

David Isaacs, Professor of Pediatric Infectious Diseases at the University of Sydney, has called for the introduction of compensation for those who suffer a serious adverse reaction to vaccination.

26 Mar 2012

Gene fault linked to flu risk for hospitalization: Study finds

Researchers have found a genetic flaw that may explain why some people get more ill with flu than others. The study was reported in the journal Nature this Sunday, where researchers said the variant of the IFITM3 gene was much more common in people hospitalized for flu than in the general population. It controls a malformed protein, which makes cells more susceptible to viral infection. Experts said those with the flaw could be given the flu jab, like other at-risk groups.

26 Mar 2012

USPTO issues patent to Inovio's SynCon H1N1 influenza vaccine

Inovio Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,133,723, covering Inovio's SynCon universal vaccine related to H1N1 influenza.

26 Mar 2012

GenVec announces data from respiratory syncytial virus vaccine program

GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the "Keystone Symposium on Viral Immunity and Host Gene Influence", which is taking place in Keystone, Colorado from March 21-26, 2012.

26 Mar 2012

Human Immunity to Tuberculosis conference to take place from April 13-14

Leading international experts in tuberculosis and related diseases from at least 10 countries will gather at a Human Immunity to Tuberculosis conference April 13-14 in Atlanta. The meeting will take place at the Emory Conference Center, 1615 Clifton Rd., Atlanta, GA 30329.

23 Mar 2012